Faculty profile

Subburaj Ilangumaran

ResearcherImmunologie-Biologie CellulaireUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Subburaj Ilangumaran

Researcher

Immunologie-Biologie Cellulaire

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
21 publications in the last five years, latest in 2026.
Senior (last) author on 11 recent papers, a sign of leading a research group.
Principal investigator on 13 research grants (9 CIHR, 4 NSERC), most recently in 2025.
Supervisor on 1 trainee award (1 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cytokines Socs1 Obesity Prostate Cancer Prostate Gland Inflammation Immune Response Aging

Latest papers

NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.
Immunotherapy advances · 2026 · senior author
Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.
Frontiers in sports and active living · 2026
Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.
Cancers · 2026

All 73 publications

Latest funding

Development of an NLRC5-based broad spectrum immunotherapeutic for immune evasive cancers
CIHR · 2025 · Nominated PI
$1,181,926
Development of an NLRC5-based broad-spectrum immunotherapeutic for immune evasive cancers
CIHR · 2024 · Supervisor
$120,000
Mechanisms of SOCS1-dependent tissue homeostasis and tumor suppression in the prostate gland
CIHR · 2024 · Nominated PI
$975,376

All 20 grants and awards

73 publications.

NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.

Shukla A, Moradzad M, Quenum AJI, Lucier JF, Armas Cayarga A, Lévesque D, Boisvert FM, Kufer TA, Ramanathan S, Ilangumaran S

Immunotherapy advances2026Senior author

DOI: 10.1093/immadv/ltag010 PMID: 42326466

Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.

Chowdhury MMH, Fontaine MN, Lord SE, Lucier JF, Allard-Chamard H, Ilangumaran S, Piché A, Dionne IJ, Ramanathan S

Frontiers in sports and active living2026

DOI: 10.3389/fspor.2026.1797346 PMID: 42294006

Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.

Rexhepi F, Ali Akbari S, Moradzad M, Khodayari S, Shukla A, Demontier E, Lucier JF, Armas Cayarga A, Allard-Chamard H, Ilangumaran S, Ramanathan S

Cancers2026

DOI: 10.3390/cancers18152499 PMID: 42588715

Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.

Chowdhury MMH, Quenum AJI, Rioux-Perreault C, Lucier JF, Ilangumaran S, Piché A, Allard-Chamard H, Ramanathan S

Scientific reports2026

DOI: 10.1038/s41598-026-46180-y PMID: 41998026

Essential Role of NLRC5 in Cancer Immune Surveillance and Cancer Immunoediting.

Shukla A, Cayarga AA, Lucier JF, Santharam MA, Quenum AJI, Ihsan AU, Lévesque D, Boisvert FM, Ramanathan S, Ilangumaran S

Scandinavian journal of immunology2025Senior author

DOI: 10.1111/sji.70047 PMID: 40820374

Impact of a tailored exercise regimen on physical capacity and plasma proteome profile in post-COVID-19 condition.

Chowdhury MMH, Fontaine MN, Lord SE, Quenum AJI, Limoges MA, Rioux-Perreault C, Lucier JF, Cliche DO, Levesque D, Boisvert FM, Cantin AM, Allard-Chamard H, Menendez A, Ilangumaran S, Piché A, Dionne IJ, Ramanathan S

Frontiers in physiology2024

DOI: 10.3389/fphys.2024.1416639 PMID: 39234310

Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon tetrachloride-induced liver fibrosis model.

Cloutier M, Variya B, Akbari SA, Rexhepi F, Ilangumaran S, Ramanathan S

Frontiers in immunology2024

DOI: 10.3389/fimmu.2024.1404891 PMID: 38919611

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.

Ilangumaran S, Gui Y, Shukla A, Ramanathan S

Frontiers in immunology2024First author

DOI: 10.3389/fimmu.2024.1362224 PMID: 38415248

The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma.

Shukla A, Khan MGM, Cayarga AA, Namvarpour M, Chowdhury MMH, Levesque D, Lucier JF, Boisvert FM, Ramanathan S, Ilangumaran S

Cancers2024Senior author

DOI: 10.3390/cancers16020292 PMID: 38254783

Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells.

Kandhi R, Menendez A, Ramanathan S, Ilangumaran S

Journal of clinical and experimental hepatology2024Senior author

DOI: 10.1016/j.jceh.2023.09.001 PMID: 38076369

Development of an NLRC5-based broad spectrum immunotherapeutic for immune evasive cancers

Nominated PICIHR2025Project Grant

Principal investigators: Ilangumaran, Subburaj; Ramanathan, Sheela

Keywords: Antigen Presentation; Cd8+ T Cells; Mhc Class-I; Mhc-I Peptide; Nlrc5; Oncolytic Virotherapy; Proteomics; Tumor Immune Evasion

$1,181,926

Development of an NLRC5-based broad-spectrum immunotherapeutic for immune evasive cancers

SupervisorCIHR2024Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: QUENUM, AKOUAVI JULITE IRMINE

Keywords: Immunoloy; Oncology

$120,000

Mechanisms of SOCS1-dependent tissue homeostasis and tumor suppression in the prostate gland

Nominated PICIHR2024Project Grant

Principal investigators: Ilangumaran, Subburaj

Keywords: Cytokines; Growth Factors; Prostate Cancer; Prostate Epithelium; Prostate Gland; Prostate Homeostasis; Prostate Hyperplasia; Socs1; Urogenital Infection; Uropathogenic E.Coli

$975,376

CIACCO- a multidisciplinary symposium on Cytokines, Immunity, Ageing, CanCer and Obesity

Co-investigatorCIHR2024Planning and Dissemination Grant - Institute Community Support

Principal investigators: Menendez, Alfredo; Ferbeyre, Gerardo

Keywords: Ageing; Cancer; Cytokines; Immunity; Infection; Infllammation; Obesity; Senescence

$12,000

Tailored exercise interventions to improve the quality of life in individuals with post-COVID-19 condition: The impact on patient's functionality and their immune and plasma proteome parameters

Co-investigatorCIHR2023Project Grant - PA: Pandemic Preparedness and Health Emergencies Research

Principal investigators: Ramanathan, Sheela; Dionne, Isabelle; Piche, Alain

Keywords: Exercise; Immune Responses; Inflammatory Parameters; Long Covid; Oxidative Stress Parameters; Post-Covid Condition

$100,000

Clinicopatholgical correlates of long COVID and potential interventions for improving the quality of life

Co-investigatorCIHR2021Op Grant: Emerging COVID-19 Research Gaps & Priorities - Post COVID-19 condition

Principal investigators: Ramanathan, Sheela; Piche, Alain

Keywords: Fatigue; Immune Responses; Inflammation; Long Covid; Physical Exercise

$490,000

Role of SOCS1 in maintaining prostate homeostasis and in suppressing malignant growth

Nominated PICIHR2021Project - PA: Cancer Prevention and Early Detection of Hard to Treat Cancers

Principal investigators: Ilangumaran, Subburaj

Keywords: Environmental Risk Factors; High Fat Diet; Homeostasis; Inflammation; Prostate Cancer; Prostate Gland; Socs1; Tissue Repair & Regeneration; Tumor Suppression; Urogenital Infections

$100,000

Understanding the contribution of DICER and microRNAs to inflammatory arthritis

Co-investigatorCIHR2021Project Grant

Principal investigators: Allard-Chamard, Hugues

Keywords: Abatacept; Autoimmunity; B Cells; Common Variable Immunodeficiency; Cytotoxic T Lymphocyte-Associated Protein 4 (Ctla4); Dicer; Immunodeficiency; Inflammatory Arthritis; Microrna

$772,650

Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness

Principal investigatorNSERC2020Discovery Grants Program - Individual

Principal investigators: Ilangumaran, Subburaj

$192,000

The role of Interleukin-15 signaling in the pathogenesis of liver fibrosis

Co-investigatorCIHR2020Project Grant

Principal investigators: Ramanathan, Sheela

Keywords: Anti-Il-15 Therapeutics; Carbon Tetrachloride; Choline-Deficient High Fat Diet; Hepatic Stellate Cells; Interleukin-15; Liver Fibrosis; Pre-Clinical Models

$1,082,476

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Subburaj Ilangumaran

Research

Latest papers

Latest funding

NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.

Aptamer-based analyses of plasma proteome in individuals with post-COVID condition who underwent tailored physical activity.

Trans-Presentation of IL-15 by IL15R&#x3b1; Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.

Distinct plasma proteome signature at 3&#xa0;months post-COVID-19 infection irrespective of post-COVID condition.

Essential Role of NLRC5 in Cancer Immune Surveillance and Cancer Immunoediting.

Impact of a tailored exercise regimen on physical capacity and plasma proteome profile in post-COVID-19 condition.

Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon tetrachloride-induced liver fibrosis model.

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.

The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma.

Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells.

Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness

Frequent collaborators

Sheela Ramanathan

Alfredo Menendez

Caroline Saucier

Hugues Allard-Chamard

Marie-France Langlois

Louis-Charles Fortier

Julie Fradette

Gerardo Ferbeyre

Gerardo Ferbeyre

Gerardo Ferbeyre

Abdelaziz Amrani

Marek Rola-Pleszczynski

Jana Stankova

Jean-Bernard Denault

David Langlais

Trang Hoang

Subburaj Ilangumaran

Christine Lavoie

Adel Schwertani

Chen Liang

Jack Antel

Nathalie Arbour

Nathalie Perreault

Jacek Majewski

Karen Mossman

Nathalie Rivard

Louis Gendron

Claire Dubois

Alexandre Prat

Philippe Gros

Mark Lathrop

Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control.

Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.